Health Catalyst Inc (HCAT) — Capital Reinvestment Ratio
Latest as of March 2026:
0.27x
Health Catalyst Inc (HCAT) has a Capital Reinvestment Ratio of 0.27x as of March 2026, meaning it reinvests 0% of its operating cash flow ($18.51 Million) in capital expenditures ($4.94 Million). See HCAT free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.27x
Capex / Operating Cash Flow
Operating Cash Flow
$18.51 Million
USD
Capital Expenditures
$4.94 Million
USD
Data as of
Mar 2026
Most recent filing
Health Catalyst Inc Capital Reinvestment Ratio (2024–2025)
This chart tracks Health Catalyst Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Health Catalyst Inc (2024–2025)
Year-by-year Capital Reinvestment Ratio for Health Catalyst Inc from 2024 to 2025. For live market cap and broader valuation context, see market value of Health Catalyst Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.32x | $731.00K | $968.00K | ▲ +17.6% |
| 2024 | 1.13x | $14.56 Million | $16.40 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow